Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
>
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

BioBanking as the Central Tool for Translational Medicine

Published: Monday, June 24, 2013
Last Updated: Monday, June 24, 2013
Bookmark and Share
Global healthcare changes forms the basis for the rapid development of centralized large scale biobank facilities.

Abstract
Globally, the health care organizations are under resource and cost constrains due to the increasing number of patients that are due to a fast increase of the 65+ age group requiring extensive medical hospitalization and treatments. Hospitals worldwide strive to seek the best cure for patients, suffering from various diseases. A consequence of these global changes, of healthy populations in relation to patients forms the basis for the build of large and centralized biobank facilities, with strategies where the search for an understanding of diseases at a molecular level is at heart. The efforts made lies within large governmental resource allocations where patient centers are collecting samples from clinical study participants in order to try to discover universal expression patterns and molecular signatures of disease and disease stages. Most developments in this area are aimed towards the discovery, and understanding diagnosis implementations. By providing the right treatment alternatives for patients care, at the right time point i.e., at a given disease stage development becomes a major goal where pharmaceutical industry, academia and the health care sector joins forces in large clinical epidemiological, population-, and disease based studies. This becomes a clear strategic link to the enhancement and prospects for personalized medicines and target directed diagnosis developments (Companion Diagnostics), which require coordinated efforts across a wide range of disciplines. Currently, companion diagnostics is at the core of the personalized medicine paradigm shift. It will identify patients who are most likely to benefit from a particular therapeutic product, as well as identify patients likely to be at increased risk for serious adverse reactions as a result of treatment with a particular therapeutic agent. It is predicted that more than half of all new drugs will require a companion diagnostic, which opens up for an endeavor for Proteomics research implementations.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biobanking in a Constantly Developing Medical World
Biomaterial resources such as tissues, cells, blood, and serum have played a critical role in academic research.
Wednesday, November 06, 2013
International Heart Valve Bank Survey: A Review of Processing Practices and Activity Outcomes
Since the first heart valve bank (HVB) started in New Zealand in 1962, the recovery, processing, and storage techniques have been constantly evolving.
Wednesday, November 06, 2013
Developing a Semantically Rich Ontology for the Biobank-Administration Domain
Recent research has provided compelling examples of using semantic web technologies, such as ontologies, to retrieve research-relevant data from biobanks.
Tuesday, October 15, 2013
Patient Understanding and Awareness of their Roles as Research Stakeholders in a Cancer Biobank
A patient’s informed consent should imply that the patient has received complete information and fully understands its meaning.
Tuesday, September 10, 2013
Telethon Network of Genetic Biobanks: a Key Service for Diagnosis and Research on Rare Diseases
Recent advances in the technology of molecular biology and genetics have contributed to raise the awareness of the importance of coordinated biobanking activity.
Tuesday, September 10, 2013
Synthetic Surface for Expansion of Human Mesenchymal Stem Cells in Xeno-Free, Chemically Defined Culture
This study evaluates the ability of the Corning Synthemax Surface to support long-term expansion of hMSCs in serum-free, defined medium.
Friday, August 16, 2013
Cryopreservation Causes Genetic and Epigenetic Changes in Zebrafish Genital Ridges
Recent studies have pointed out that cryopreservation can cause molecular alterations in cells at different levels that may interfere with normal embryo development.
Thursday, July 18, 2013
Establishing a Southern Swedish Malignant Melanoma OMICS and Biobank Clinical Capability
Current research developments and future healthcare solutions are expected to be closely linked to the utility of biobank initiatives.
Friday, March 22, 2013
Effect of Different Freezing Rates During Cryopreservation of Rat MSCs using Combinations of HES and DMSO
In this study researchers from Fraunhofer Institute for Cell Therapy and Immunology attempt an initial comparison of two independent factors: freezing rates and cryopreservation.
Thursday, November 08, 2012
Cryopreserved Reticulocytes Derived from Stem Cells can be Invaded by Cryopreserved Plasmodium vivax Isolates
The cryopreservation method described in this paper provides a continuous and substantial source of reticulocytes, possibly a first step to achieve the continuous in vitro culture of P. vivax.
Wednesday, November 07, 2012
New national Biobank of The Danish Center for Strategic Research on Type 2 Diabetes
This paper aims to describe the biobank logistics and how the biological samples are collected, handled, shipped and stored.
Friday, November 02, 2012
Human Blood RNA Stabilization in Samples Collected and Transported for a Large Biobank
The study strongly suggests that special collection tubes are necessary for RNA stabilization and they should be used for establishing new biobanks.
Friday, October 05, 2012
Biobanking for Health Research in Brazil: Present Challenges and Future Directions
This article outlines and discusses Brazil's new regulations on the use of human biological materials for research.
Monday, September 10, 2012
Evaluation of Distinct Freezing Methods and Cryoprotectants for Human Amniotic Fluid Stem Cells Cryopreservation
Researchers from the University of São Paulo Medical School have evaluated the effects of two cryopreservation methods and four distinct cryoprotectants in the AFSCs viability and main characteristics maintenance after liquid nitrogen storage.
Monday, August 06, 2012
IT Solutions for Privacy Protection in Biobanking
In this article, researchers from the University of Klagenfurt discuss current European public opinion on privacy issues and concerning informed consent, proposing IT solutions that help to harmonize research needs and societal demands.
Saturday, August 04, 2012
Scientific News
The Mending Tissue - Cellular Instructions for Tissue Repair
NUS-led collaborative study identifies universal mechanism that explains how tissue shape regulates physiological processes such as wound healing and embryo development.
Tissue Bank Pays Dividends for Brain Cancer Research
Checking what’s in the bank – the Brisbane Breast Bank, that is – has paid dividends for UQ cancer researchers.
iPS Cells Discover Drug Target for Muscle Disease
Researchers have designed a model that reprograms fibroblasts to the early stages of their differentiation into intact muscle cells in a step towards a therapeutic for Duchenne muscular dystrophy.
Engineered Hot Fat Implants Reduce Weight Gain
Scientists at UC Berkeley have developed a novel way to engineer the growth and expansion of energy-burning “good” fat, and then found that this fat helped reduce weight gain and lower blood glucose levels in mice.
Transplanted Stem Cells Can Benefit Retinal Disease Sufferers
Tests on animal models show that MSCs secrete growth factors that suppress causes of diabetic retinopathy and macular degeneration.
MRI Scanners Can Steer Therapeutics to Specific Target Sites
Scientists from the University of Sheffield have discovered MRI scanners, normally used to produce images, can steer cell-based, tumour busting therapies to specific target sites in the body.
Team Finds Early Inflammatory Response Paralyzes T Cells
Findings could have enormous implications for immunotherapy, autoimmune disorders, transplants and other aspects of immunity.
Early Detection of Lung Cancer
The University of Manchester has signed a collaboration agreement with Abcodia to perform proteomics studies on a cohort of non-small cell lung cancer cases from the UKCTOCS biobank, with the aim of discovering new blood-based biomarkers for earlier detection of the disease.
Researchers Identify Drug Candidate for Skin, Hair Regeneration
Formerly undiscovered role of protein may lead to the development of new medications that stimulate hair and skin regeneration in trauma or burn victims.
Basis for New Treatment Options for a Fatal Leukemia in Children Revealed
Detailed molecular analyses allow new insights into the function of tumour cells and options for new treatments.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!